| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.008 |